|
C3ORF58 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.807760E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.027700E-02 |
| Normal-vs-Stage2 |
5.149400E-01 |
| Normal-vs-Stage3 |
3.818400E-01 |
| Normal-vs-Stage4 |
5.421600E-01 |
| Stage1-vs-Stage2 |
5.068200E-01 |
| Stage1-vs-Stage3 |
4.805900E-02 |
| Stage1-vs-Stage4 |
1.718380E-01 |
| Stage2-vs-Stage3 |
2.416600E-01 |
| Stage2-vs-Stage4 |
3.924000E-01 |
| Stage3-vs-Stage4 |
9.673000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.162100E-02 |
| Normal-vs-AfricanAmerican |
6.880600E-01 |
| Normal-vs-Asian |
7.559000E-01 |
| Caucasian-vs-AfricanAmerican |
6.627400E-01 |
| Caucasian-vs-Asian |
4.376400E-01 |
| AfricanAmerican-vs-Asian |
7.539800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.879800E-03 |
| Normal-vs-Female |
1.643210E-01 |
| Male-vs-Female |
3.664000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.766200E-01 |
| Normal-vs-Extreme_Weight |
3.399200E-03 |
| Normal-vs-Obese |
5.302800E-01 |
| Normal-vs-Extreme_Obese |
7.461600E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.644000E-01 |
| Normal_Weight-vs-Obese |
8.428600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.571970E-01 |
| Extreme_Weight-vs-Obese |
1.187220E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.640800E-01 |
| Obese-vs-Extreme_Obese |
8.265600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.992200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.021800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.135700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.593650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.567400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.719800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.417960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.243500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.611600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.073600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.742320E-03 |
| Normal-VS-Type2 PRCC |
5.561600E-01 |
| Normal-VS-KIRP CIMP |
5.823900E-02 |
| Normal-VS-Unclassified PRCC |
6.937000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.517000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.459600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.969700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.999300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.203400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.218000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.058600E-01 |
| Normal-vs-N1 |
1.293970E-01 |
| Normal-vs-N2 |
7.405400E-01 |
| N0-vs-N1 |
6.848000E-02 |
| N0-vs-N2 |
6.607600E-01 |
| N1-vs-N2 |
8.701600E-01 |
|
|
